PharmaShots | Incisive News in 3 Shots

Subscribe Now

first

Mirum's Livmarli (maralixibat) Receives US FDA's Approval as the First Approved Therapy for Cholestatic Pruritus in Patients with Alagille Syndrome

Mirum's Livmarli (maralixibat) Receives US FDA's Approval as the First Approved Therapy for Cholestatic Pruritus in Patients with...

September 29, 2021

Daiichi Sankyo Reports First patient Dosing in P- I/II Trial of DS-1594 to Treat Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia

Daiichi Sankyo Reports First patient Dosing in P- I/II Trial of DS-1594 to Treat Acute Myeloid Leukemia and Acute Lymphoblastic Le...

April 8, 2021

G1 Therapeutics and Boehringer Ingelheim Launch Cosela (trilaciclib) in the US

G1 Therapeutics and Boehringer Ingelheim Launch Cosela (trilaciclib) in the US

March 3, 2021

Takeda Collaborates with Ensoma to Accelerate Next-Generation In Vivo Gene Therapies

Takeda Collaborates with Ensoma to Accelerate Next-Generation In Vivo Gene Therapies

February 12, 2021

Pfizer Reports the First Patients Dosing of PF-06939926 in P-III CIFFREO Study for DMD

Pfizer Reports the First Patients Dosing of PF-06939926 in P-III CIFFREO Study for DMD

January 8, 2021

Medtronic Launches Carpediem as the First Pediatric and Neonatal Acute Dialysis Machine in the US

Medtronic Launches Carpediem as the First Pediatric and Neonatal Acute Dialysis Machine in the US

December 9, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us